We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

dinsdag 21 maart 2017

Latest content from npj Precision Oncology: 21 March 2017

If you are unable to see the message below, click here to view.
npj Precision Oncology

Table of Contents: March 2017

Review Article | 20 March 2017

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma

Dana S. Neel & Trever G. Bivona

npj Precision Oncology 1, Article number: s41698-017-0007-0 | doi: 10.1038/s41698-017-0007-0

Brief Communication | 20 March 2017

Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor

Christopher Alvarez-Breckenridge, Julie J. Miller, Naema Nayyar, Corey M. Gill, Andrew Kaneb et al.

npj Precision Oncology 1, Article number: s41698-017-0009-y | doi: 10.1038/s41698-017-0009-y

Case Reports | 20 March 2017

ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor

Sebastian Y. F. Michels, Andreas H. Scheel, Thomas Wündisch, Johannes M. Heuckmann, Roopika Menon et al.

npj Precision Oncology 1, Article number: s41698-017-0004-3 | doi: 10.1038/s41698-017-0004-3

Perspective | 20 March 2017

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling

Feng Liu, Paul S. Mischel & Webster K. Cavenee

npj Precision Oncology 1, Article number: s41698-017-0005-2 | doi: 10.1038/s41698-017-0005-2

Editorial | 20 March 2017

Precision oncology- the future of personalized cancer medicine?

Ann M. Bode & Zigang Dong

npj Precision Oncology 1, Article number: s41698-017-0010-5 | doi: 10.1038/s41698-017-0010-5

nature.com webcasts

Join us for our upcoming webcast followed by live Q&A:

Presented by BioPharma Dealmakers

Date: Wednesday, March 29, 2017
Time: 8AM PDT | 11AM EDT | 4PM BST | 5PM CEST


Sponsored by: Corium International | Portal Instruments Inc. | TissueGen Inc. | TrioxNano
Your email address is in the npj Precision Oncology mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature